Physician

Richard Scott Cornell, MD

According to 2025 Medicare claims, Richard Cornell, MD (NPI: 1376545327) practices nephrology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF KENTUCKIANA PSC (NPI: 1730161753; TIN: 611141697) and primary practice location at 40205-3354.

Cornell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 900 traditional Medicare patients, billed 3,546 HCPCS/CPT codes, and received $261,038 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 754 prescription claims across 219 beneficiaries totaling $190,198 in drug costs, led by Jardiance (Empagliflozin). 2019 DME data shows 38 claims. Open Payments data shows 8 records totaling $297. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $129,309 and ending at $190,198. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	837	3,449	$299,887
2016	768	2,914	$268,426
2017	881	3,139	$309,334
2018	818	2,939	$315,474
2019	835	2,899	$309,483
2020	828	2,577	$280,851
2021	775	2,383	$258,932
2022	775	2,203	$223,219
2023	837	2,440	$228,477
2024	900	3,546	$261,038

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	1,351	$129,309
2016	219	1,341	$161,760
2017	262	1,119	$154,454
2018	274	1,287	$89,412
2019	301	1,192	$108,640
2020	264	1,345	$121,429
2021	247	1,230	$96,801
2022	213	769	$39,731
2023	217	893	$193,735
2024	219	754	$190,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	100	$17,886
2016	N/R	65	$9,363
2017	N/R	57	$8,545
2018	N/R	103	$13,600
2019	N/R	38	$1,127
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	89	110	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	446	625	$60
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	317	826	$57
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	73	375	$36
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	456	646	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	103	3,845	$74,412
Velphoro	Sucroferric Oxyhydroxide	19	510	$48,027
Renvela	Sevelamer Carbonate	13	930	$27,403
Farxiga	Dapagliflozin Propanediol	27	880	$16,559
Sevelamer Carbonate	Sevelamer Carbonate	25	975	$2,049

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$297	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Scott Cornell, MD?

Tedicare shows public-source Medicare data for Richard Scott Cornell, MD (NPI 1376545327), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Scott Cornell, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Scott Cornell, MD?

Richard Scott Cornell, MD is linked to NEPHROLOGY ASSOCIATES OF KENTUCKIANA PSC (billing NPI 1730161753) in the available physician profile data.

Does Richard Scott Cornell, MD have Open Payments data?

Richard Scott Cornell, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.